Erba Diagnostics, Revenue Growth Rates (IVD), Current and Historic Growth - CSIMarket
CSIMarket
 


Erba Diagnostics, Inc.  (IVD)
 

IVD's Revenue Growth by Quarter and Year

Erba Diagnostics,'s Revenue results by quarter and year




IVD Revenue (in millions $) FY 2014 FY 2013 FY 2012 FY 2011
4th Quarter December -
3rd Quarter September -
2nd Quarter June -
1st Quarter March 4.85
FY 4.85





IVD Revenue first quarter 2014 Y/Y Growth Comment
Erba Diagnostics, Inc. reported Revenue increase of 13.66% year on year in the first quarter 2014, to $ 4.85 millions, this is lower than Erba Diagnostics, Inc.'s recent average Revenue increase of 14.33%.

Looking into first quarter 2014 results within Laboratory Analytical Instruments industry 21 other companies have achieved higher Revenue growth. While Erba Diagnostics, Inc.' s Revenue growth of 13.66% ranks overall at the positon no. 3131 in the first quarter 2014.




IVD Revenue ( Y/Y Growth %) 2014
2013 2012 2011
4th Quarter December - 43.44 % 6.08 % -
3rd Quarter September - 59.36 % -7.52 % -
2nd Quarter June - 72.15 % - -
1st Quarter March 13.66 % 3.39 % - -
FY   - 44.93 % 100.96 % -

Financial Statements
Erba Diagnostics,'s first quarter 2014 Revenue $ 4.85 millions IVD's Income Statement
Erba Diagnostics,'s first quarter 2013 Revenue $ 4.27 millions Quarterly IVD's Income Statement


IVD Revenue (Quarter on Quarter Growth %)

2014
2013 2012 2011
4th Quarter December - -7.11 % 3.2 % -10.02 %
3rd Quarter September - -14.19 % -7.31 % -
2nd Quarter June - 76.58 % 6.05 % -
1st Quarter March -19.25 % 1.91 % 4.56 % -
FY (Year on Year)   - 44.93 % 100.96 % -




Revenue first quarter 2014 Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #22
Healthcare Sector #335
Overall #3131

Revenue Y/Y Growth Statistics
High Average Low
14.33 % 14.33 % 14.33 %
(Sep 30 2014)  
Revenue first quarter 2014 Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #22
Healthcare Sector #335
Overall #3131
Revenue Y/Y Growth Statistics
High Average Low
14.33 % 14.33 % 14.33 %
(Sep 30 2014)  

Revenue by Quarter for the Fiscal Years 2011, 2012, 2013, 2014

Erba Diagnostics,'s Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
5.82 % -5.85 % -19.25 %
(Jun 30 2011)  


IVD's I. Quarter Q/Q Revenue Comment
In the I. Quarter 2014 Erba Diagnostics, Inc. disclosed fall in Revenue from the fourth quarter by -19.25% to $ 4.85 millions, from $ 6.01 millions achived in the previous reporting period.

Although periodic circumstance commonly energize I. Quarter 2014 Revenue, this plainly could not be substantial to rescue Laboratory Analytical Instruments's company achievement, Most analysts pointed out.

Within Laboratory Analytical Instruments industry 23 other companies have achieved higher Revenue quarter on quarter growth. While Erba Diagnostics,'s Revenue growth quarter on quarter, overall rank is 3885.


Revenue Q/Q Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #24
Healthcare Sector #456
Overall #3885
Revenue Q/Q Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #24
Healthcare Sector #456
Overall #3885
Revenue Q/Q Growth Statistics
High Average Low
5.82 % -5.85 % -19.25 %
(Jun 30 2011)  


IVD's I. Quarter Q/Q Revenue Comment
In the I. Quarter 2014 Erba Diagnostics, Inc. disclosed fall in Revenue from the fourth quarter by -19.25% to $ 4.85 millions, from $ 6.01 millions achived in the previous reporting period.

Although periodic circumstance commonly energize I. Quarter 2014 Revenue, this plainly could not be substantial to rescue Laboratory Analytical Instruments's company achievement, Most analysts pointed out.

Within Laboratory Analytical Instruments industry 23 other companies have achieved higher Revenue quarter on quarter growth. While Erba Diagnostics,'s Revenue growth quarter on quarter, overall rank is 3885.


Erba Diagnostics,'s 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2014)
12 Months Ending
(Jun 30 2014)
12 Months Ending
(Mar 31 2012)
12 Months Ending
(Dec 31 2011)
12 Months Ending
Cumulative Revenue 12 Months Ending $ 27.01 $ 0.00 $ 0.00 $ 0.00 $ 0.00
Y / Y Revenue Growth (TTM) 14.33 % - - - -
Year on Year Revenue Growth Overall Ranking # 1107 # 982 # 0 # 0 # 0
Seqeuential Revenue Change (TTM) -15.03 % - - - -
Seq. Revenue Growth (TTM) Overall Ranking # 3131 # 2621 # 0 # 0 # 0


Cumulative Revenue growth Comment
With 14.33% annual Revenue growth, Erba Diagnostics, Inc. would report a record annual Revenue increase if the fiscal year would end on Sep 30 2014.

In the Healthcare sector 144 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 982 to 1107.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 22
Healthcare Sector # 145
Overall # 1107

Revenue TTM Y/Y Growth Statistics
High Average Low
14.33 %
14.33 %
14.33 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 22
Sector # 335
S&P 500 # 3131
Cumulative Revenue growth Comment
With 14.33% annual Revenue growth, Erba Diagnostics, Inc. would report a record annual Revenue increase if the fiscal year would end on Sep 30 2014.

In the Healthcare sector 144 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 982 to 1107.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 22
Healthcare Sector # 145
Overall # 1107

Revenue TTM Y/Y Growth Statistics
High Average Low
14.33 %
14.33 %
14.33 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 22
Sector # 335
S&P 500 # 3131




Other Revenue Growth
Laboratory Analytical Instruments Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
IVD's Revenue Growth Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue increase for the quarter ending Mar 31 2015 within Healthcare SectorY/Y Change %Revenue for the quarter ending Mar 31 2015
Labcorp Holdings Inc 23.88%$ 23.876 millions
Alkermes Plc 23.81%$ 23.809 millions
Clearpoint Neuro Inc 22.84%$ 22.841 millions
China Yct International Group, Inc.22.79%$ 22.790 millions
Tetraphase Pharmaceuticals Inc22.75%$ 22.751 millions
Horizon Therapeutics Public Limited Company22.65%$ 22.649 millions
Applied Genetic Technologies Corporation22.41%$ 22.414 millions
Tenet Healthcare Corp22.03%$ 22.033 millions
Caredx Inc 21.81%$ 21.810 millions
Sientra Inc 21.57%$ 21.568 millions
Five Prime Therapeutics Inc 20.90%$ 20.897 millions
Allergan plc20.47%$ 20.467 millions
Seagen Inc 20.34%$ 20.340 millions
Atricure Inc 20.28%$ 20.280 millions
Celgene Corp20.28%$ 20.277 millions
Endo International Plc20.10%$ 20.100 millions
Elite Pharmaceuticals Inc 20.04%$ 20.039 millions
Biogen Inc 19.97%$ 19.965 millions
Bio techne Corp19.47%$ 19.468 millions
Luna Innovations Inc19.39%$ 19.393 millions
Lineage Cell Therapeutics Inc 18.55%$ 18.546 millions
Innovage Holding Corp 18.52%$ 18.523 millions
Panbela Therapeutics Inc 18.29%$ 18.295 millions
Lhc Group Inc 17.96%$ 17.961 millions
Cutera Inc 17.80%$ 17.802 millions
Cambrex Corp17.28%$ 17.276 millions
Phio Pharmaceuticals Corp17.24%$ 17.241 millions
Nanomix Corp17.12%$ 17.117 millions
Vertex Pharmaceuticals Inc16.93%$ 16.934 millions
Adm Tronics Unlimited Inc 16.89%$ 16.894 millions


About Erba Diagnostics, Revenue Growth Rates (IVD), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: the company’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.